Association between C-reactive protein and age-related macular degeneration. - Wikidata - wikimedia - TriplyDB

Association between C-reactive protein and age-related macular degeneration.

Association between C-reactive protein and age-related macular degeneration.

http://www.wikidata.org/entity/Q51051730

about

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration Complement factor H polymorphism in age-related macular degeneration Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19 Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes Parainflammation, chronic inflammation, and age-related macular degeneration Genetic and environmental underpinnings to age-related ocular diseases RPE necroptosis in response to oxidative stress and in AMD IKK2 inhibition attenuates laser-induced choroidal neovascularization Genetic markers and biomarkers for age-related macular degeneration.Animals as models of age-related macular degeneration: an imperfect measure of the truth.The association between periodontal disease and age-related macular degeneration in the Korea National health and nutrition examination survey: A cross-sectional observational study.Risk factors for age-related maculopathy The role of CRP and inflammation in the pathogenesis of age-related macular degeneration.Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up.Obesity and inflammation: the linking mechanism and the complications Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response.Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration.Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis.Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.[Age-related macular degeneration and risk of stroke].Smoking and age-related macular degeneration: review and update Elevated C-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration.Prevention of age-related macular degeneration Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women Visual improvement following ozonetherapy in dry age related macular degeneration; a review The reduction of serum soluble Flt-1 in patients with neovascular age-related macular degeneration Healthy lifestyles related to subsequent prevalence of age-related macular degeneration.Haplotypes in IL-8 Gene Are Associated to Age-Related Macular Degeneration: A Case-Control Study.Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration Intravitreal injection of (99)Tc-MDP inhibits the development of laser-induced choroidal neovascularization in rhesus monkeys.Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium Lipids, lipoproteins, and age-related macular degeneration Assessment of Neutrophil/Lymphocyte Ratio in Patients with Age-related Macular Degeneration.Reconsidering the connection between vitamin D levels and age-related macular degeneration.Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMD.

P2860

Q24523983-CDF8EB50-1845-4364-9102-E800FB9FE5D1 Q24553334-3003723F-5C84-4772-9DFB-1101CA48DDB5 Q24554181-80526A5B-F911-4566-A955-808F39FB7489 Q24644120-EFA92E2F-9B65-45C3-A94A-4CBEC3884474 Q26796268-2EB70066-A2A2-4EE1-9F16-4A0A43667E57 Q27013719-E4401AE6-3703-4C27-9F7F-15EE6E33009B Q27693234-4D26D27C-573A-446F-9A42-336512D423DA Q28539266-70BA7905-BE45-4081-80C2-8CE18FA03196 Q33301643-F7919619-F530-4460-955D-C8B35BC4C2A3 Q33552165-9DEF6B2E-0FFF-4907-8837-17B4DC9E7BC2 Q33621228-FDA997D4-A449-4962-8690-8673AFEE5A6C Q33720834-DA7F84A8-8A90-4353-B6A0-E13834885EDA Q33773157-8E24C454-BABF-4CF9-A517-7137844CF181 Q33787737-DEFA8043-13BB-4243-B437-0223E2A45590 Q33855388-B6DC308E-98F7-45F7-8E2B-AB0C57701E19 Q33875857-447C62DD-47FA-4633-9594-3956871726F2 Q33897331-59B0A652-FAD8-4753-AAF6-37C3872D687E Q33911788-EF745B93-F26B-49C6-9983-ABB74ED970BD Q34003267-1ED366FD-22EE-4AF3-9929-73E7B73FFB1D Q34021032-1D26200C-2405-4533-B318-85B8A8A06B4A Q34114772-1AF46ADD-8289-4B71-BEAF-76A93B587296 Q34214289-8A3248B8-A2B2-4821-B685-B71120773C62 Q34389315-9A17AEAF-ACDE-487C-893B-9C371686B271 Q34394380-343787FF-91AD-4D95-8CAA-CC59E68E9A54 Q34452910-C7E6E889-C336-4169-B41B-73A112193058 Q34491498-1D449AAF-2522-4DD7-8367-078C07FF7B0C Q34518507-3B5756DB-D8BD-4D5D-8286-A293537F5C92 Q34565911-0B02000C-82F5-46AC-9B7C-3B08E3450B8A Q34660205-DF5A6E2E-1789-4970-975F-A1EF65C7CE7B Q34674568-66BAD40A-615C-48C5-AD37-0745B7AED97B Q34785911-5FDECF91-1445-45DA-B266-0E8E27622F52 Q34806228-0D3BCF36-CC2C-4014-9CCE-38B6ED0E17E9 Q34847083-FBE16982-71BF-45C2-BCBD-C55C7AD3695B Q35081925-2BB00998-8E37-49CC-9D16-A1AF147672DD Q35118257-CD5253BF-D28B-4B70-8E19-AC264B465211 Q35133725-21AC14DA-94C4-4FFC-9689-7F1D04660D89 Q35138088-6671593A-9CE2-488F-8261-AE3271235761 Q35200030-C7049467-1D4C-46BC-8885-B614D1E05ED8 Q35209885-FD274B6B-45A0-4D4D-9CEE-D92D26C2ED99 Q35220974-3B54B6AE-4FB2-4E8A-911F-799C54A372B3

P2860

Association between C-reactive protein and age-related macular degeneration.

http://www.wikidata.org/entity/Q51051730

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Association between C-reactive protein and age-related macular degeneration.

@en

Association between C-reactive protein and age-related macular degeneration.

@nl

type

label

Association between C-reactive protein and age-related macular degeneration.

@en

Association between C-reactive protein and age-related macular degeneration.

@nl

prefLabel

Association between C-reactive protein and age-related macular degeneration.

@en

Association between C-reactive protein and age-related macular degeneration.

@nl

P1433

Q51051730-CB0D0127-5A7C-4170-8BB1-5B9D73440A77

P1476

Q51051730-D86A4DE8-FBAA-458B-B068-5EAD01F2DBAC

P2093

Q51051730-51BC273B-0B27-415F-A792-DD5D17552BB0

Q51051730-72AFD1FF-1E72-4683-890D-38590E657652

Q51051730-8766791E-AB83-4DE2-9AA0-C07D66300141

Q51051730-BE88FDDC-94EE-4CC7-80D2-3BB6524D0AC5

Q51051730-C2955D88-2BA8-4D57-B648-FB4B45AEFDC1

P304

Q51051730-7109BFDF-137D-4C19-8D7A-9CC94F93CE30

P31

Q51051730-4D1AA594-7883-4F5A-A19F-85875A4D19B2

P356

Q51051730-0B548C29-BB0C-436B-81DA-830FAD0F9B09

P407

Q51051730-8A1D166A-2F02-43C1-B8ED-578A564282D6

P433

Q51051730-3184A4CA-F53D-4891-A394-E4B742D8D76B

P478

Q51051730-FE159134-520A-48F7-AE71-7741C4813880

P577

Q51051730-C2BDD942-DDFA-4B05-A47D-F24D663E94C7

P5875

Q51051730-F9E1BA34-4888-44E7-8019-3AC85EF24AD8

P698

Q51051730-93C7459E-E809-40C2-B854-139118AA7297

P356

P1433

Journal of the American Medical Association

P1476

Association between C-reactive protein and age-related macular degeneration.

@en

P2093

Gary Gensler

http://www.w3.org/2001/XMLSchema#string

Johanna M Seddon

http://www.w3.org/2001/XMLSchema#string

Michael L Klein

http://www.w3.org/2001/XMLSchema#string

Nader Rifai

http://www.w3.org/2001/XMLSchema#string

Roy C Milton

http://www.w3.org/2001/XMLSchema#string

P304

704-710

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.291.6.704

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

291

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8778376

http://www.w3.org/2001/XMLSchema#string

P698

14871913

http://www.w3.org/2001/XMLSchema#string